Infinimmune, a San Francisco, CA-based biotechnology firm, raised $12M in Seed funding.
The spherical was led by Playground International, with participation from Pear VC, Civilization Ventures, Axial VC, Ron Alfa, Jacob Becraft, Paul Conley, and Joshua Meier.
The corporate intends to make use of the funds to develop workforce of expertise, develop R&D capabilities, and scale operations.
Based by Wyatt McDonnell, Katie Pfeiffer, Mike Gibbons, Lance Hepler, and David Jaffe, Infinimmune is a biotechnology firm with an end-to-end platform to ship antibody medication derived instantly from the human immune system. These human antibodies are designed to drug new and present targets with improved security and efficacy.
Infinimmune will deploy its holistic method to construct its personal pipeline of drug candidates and associate with pharmaceutical corporations to advance their antibody applications, fill their pipelines, and attain new sufferers and new indications.